The quality‐adjusted time without symptoms of disease or toxicity method improves on the current benchmarks of overall and progression‐free survival by adding adverse events and utility coefficients to account for patients' quality of life. This will provide patients and their caregivers with additional information critical to making treatment decisions.See also pages 2294‐302.